The grades of four medical devices stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.
This week, Winner Medical Group (WWIN) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
This week, Antares Pharma, Inc. (ATRS) is showing significant improvement as the company’s rating hops from a C (“hold”) to a B (“buy”). Antares Pharma develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. For more information, get Portfolio Grader’s complete analysis of ATRS stock.
Neovasc Inc. (NVCN) gets a higher grade this week, advancing from a B last week to an A. For more information, get Portfolio Grader’s complete analysis of NVCN stock.
Medtronic, Inc. (MDT) improves from a C to a B rating this week. Medtronic develops therapeutic and diagnostic medical products. For more information, get Portfolio Grader’s complete analysis of MDT stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.